Stock DNA
Non Banking Financial Company (NBFC)
INR 45 Cr (Micro Cap)
NA (Loss Making)
23
0.00%
0.00
-46.60%
5.23
Total Returns (Price + Dividend) 
Pan India Corpor for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Why is Pan India Corpor falling/rising?
As of 17-Nov, Pan India Corporation Ltd's stock price is currently at 2.15, reflecting an increase of 0.02 or 0.94%. The stock has shown a trend reversal, gaining after three consecutive days of decline. Despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 203.64% on November 14 compared to the 5-day average. However, the stock has underperformed against the benchmark indices over various periods, with a year-to-date decline of 36.01% compared to the Sensex's gain of 8.72%. In the broader market context, while Pan India Corporation's stock has experienced a short-term rise, it has still lagged significantly behind the Sensex, which has gained 1.69% over the past week. This underperformance is eviden...
Read MoreIs Pan India Corpor overvalued or undervalued?
As of 23 October 2025, the valuation grade for Pan India Corpor has moved from very expensive to risky, indicating a significant shift in its perceived value. The company is currently considered undervalued, with a price-to-earnings (PE) ratio of -12.36, a price-to-book value of 0.58, and an EV to EBITDA ratio of -11.83. These ratios suggest that the company is trading at a discount relative to its intrinsic value, despite the negative earnings. In comparison to its peers, Pan India Corpor's valuation metrics stand out. For instance, Bajaj Finance has a PE ratio of 39.07, while Life Insurance boasts a PE of 11.68, both indicating much higher valuations. The stark contrast with these peers reinforces the notion that Pan India Corpor is undervalued. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -31.85% compared to the Sensex's 8.21%, further ...
Read MoreIs Pan India Corpor overvalued or undervalued?
As of 17 October 2025, the valuation grade for Pan India Corpor has moved from risky to very expensive. This indicates a significant shift in the company's perceived value, suggesting that it is currently overvalued. The company exhibits a PE ratio of -12.09, an EV to EBIT of -11.56, and a Price to Book Value of 0.56, all of which highlight its financial struggles and negative profitability metrics. In comparison to its peers, Pan India Corpor's valuation stands out as particularly unfavorable. For instance, Bajaj Finance has a PE ratio of 38.21, while Life Insurance boasts a PE of 11.49, both indicating a more robust financial position relative to Pan India Corpor. Additionally, the company's recent stock performance has underperformed against the Sensex, with a year-to-date return of -33.33% compared to the Sensex's 7.44%, further reinforcing the notion that Pan India Corpor is overvalued in the current ...
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Oct-2025 | Source : BSEPursuant to Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 please find enclosed herewith scanned copy of Newspaper release of the Financial Results for the Quarter and Half Year Ended 30.09.2025.
Un- Audited Standalone Financial Results For Quarter And Half Year Ended 30.09.2025
14-Oct-2025 | Source : BSEThe Board of Directors at its meeting held today i.e Tuesday 14th October 2025 have approved the Un-audited Standalone Financial Results for the Quarter and Half Year Ended 30.09.2025.
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 14TH OCTOBER 2025
14-Oct-2025 | Source : BSEThe Board of Directors at its meeting held today i.e. 14th October 2025 have considered and approved the following agenda items: A) The Un-Audited Standalone Financial Results for the Quarter and Half Year Ended 30th September 2025; B) Any other items as mentioned in the agenda.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Vizwise Commerce Private Limited (45.51%)
None
53.13%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 15.79% vs 94.77% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -40.00% vs 65.75% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -100.00% vs 0.00% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 44.64% vs -154.55% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
YoY Growth in year ended Mar 2025 is -4,825.00% vs 90.91% in Mar 2024






